NDC 60505-751 - Ceftriaxone Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-751
Manufacturer
Rebel Distributors Corp
Effective date
2011-01-17
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ceftriaxone Sodium - Rebel Distributors CorpRebel Distributors Corp2011-01-17HUMAN PRESCRIPTION DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFTRIAXONE SODIUMACTIVE INGREDIENT023Z5BR09KCEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [REBEL DISTRIBUTORS CORP]2
CEFTRIAXONEACTIVE MOIETY75J73V1629CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [REBEL DISTRIBUTORS CORP]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutions1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c2024-01-31Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutionsff8e830a-c288-46fb-9e19-ec2017943c072024-01-31Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
ceftriaxoneCEFTRIAXONESagent Pharmaceuticals5cf93bc5-9e4c-4734-bc02-c7d0ac0710222023-11-08Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEFresenius Kabi USA, LLC7ea1db43-40fa-417b-8911-ae98092070a02023-09-30Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMAsclemed USA, Inc.f01cf0e5-caaf-4759-ba21-50f3aceff5232023-09-02Warnings, Adverse reactionsExact identifier
rxcui: 1665005
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMApotex Corp.5116231f-82d1-44be-b08e-560c9a50e5c52023-08-31Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMApotex Corp.ac03a72c-0e35-40f9-b7fc-081badb5f19c2023-01-28Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONE SODIUMSamson Medical Technologies, LLC5cd2d96f-83e5-4326-ae87-d0ede4ba493a2023-01-15Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEProficient Rx LPfcf401df-bcdc-4773-a63b-9741c0f74b3d2022-11-01Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMProficient Rx LPa25ab5ea-c46d-4562-8f7e-0ccffc2ab0692022-10-01Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMProficient Rx LP42ba7a9d-7d2b-4eac-af59-897151a8c9242022-05-02Warnings, Adverse reactionsExact identifier
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc9d1f630b-e759-4395-9d01-ddc90e4fea752022-03-09Warnings, Adverse reactionsExact identifier
rxcui: 1665021
unii: 023Z5BR09K
CEFTRIAXONE AND DEXTROSECEFTRIAXONEB. Braun Medical Inc.67153914-16bc-490d-82d7-6380616184672022-01-13Warnings, Adverse reactionsExact identifier
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEHikma Pharmaceuticals USA Inc.8351aa37-552d-471d-b293-c564dcb6ec292021-12-01Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEHikma Pharmaceuticals USA Inc.1f8776bd-4f5b-427a-849a-6b8338f7997d2019-04-24Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
848653f3-ea81-4416-94a5-9dc0327cd2e3473ab78d-5015-4a4a-8a2c-8f594b8de41d2011-01-17Warnings, Adverse reactionsExact identifier
spl id: 848653f3-ea81-4416-94a5-9dc0327cd2e3
spl set id: 473ab78d-5015-4a4a-8a2c-8f594b8de41d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.